Posts

Researchers Receive $1 Million Grant to Study Digital Screening Intervention Tool for Adolescents and Young Adults

cliexa is excited to partner with the University of Northern Colorado (UNC) with a grant from the Department of Health and Human Services’ Office of Adolescent Health that provides nearly one million dollars over the next two years for the implementation of cliexa-OPTIONS, a digital screening intervention tool that fosters earlier identification of high-risk adolescents in a clinical setting. The funding supports independent evaluation including, cost-benefit analysis and randomized controlled trial of the cliexa-OPTIONS risk screening tool and MyPLAN mobile health follow-up. The Principal Investigator for the project at UNC is Dr. William Merchant. He is the evaluation professor in the Applied Statistics and Research Methods program in the College of Education and Behavioral Sciences. 

The cost-benefit analysis assesses cost savings between the cliexa-OPTIONS risk screening against current paper pencil and verbal screenings. Also, the cliexa-OPTIONS risk screening identifies 30- 50% more risk in adolescent populations fostering early identification of adolescents at highest risk for acquiring an STI or experiencing an unplanned pregnancy. Improving quality in clinical workflows for adolescent and young adult populations is timely, given that sexually transmitted infections for young people ages 15 -24 are at epidemic proportions.

Saving time and keeping providers satisfied with new technology in clinical workflows is no simple task. The cost-benefit analysis will also assess the benefits of early identification of adolescents at highest risk for adverse reproductive health outcomes, substance use, mental health, and wellness.

Read the full article at: //www.unco.edu/news/newsroom/releases/million-dollar-grant-digital-screening-intervention-tool.aspx

Digital health benefits

2018 has seen a significant boom in the application of technology in digital health innovation, which are poised to disrupt the healthcare industry. Innovations have included advances in mobile health (mHealth), health information technology (IT), as well as wearable and Internet-of-Things (IoT) devices.

cliexa has identified six specific areas of medicine already reaping the benefits of digital health innovation:

1. Rheumatology

Disease Activity Scoring (DAS) metrics remotely collected by cliexa from patients are used by physicians in their offices when assessing the severity of rheumatoid arthritis through a Q & A approach. cliexa empowers patients with the ability to communicate their patient-reported outcomes to their physicians at the touch of a finger, on their own mobile devices, providing physicians with instantly-scored clinically-validated assessments. The application of cliexa innovations in rheumatology drastically increases the efficiency and quality-of-care for both patients and their providers.

Check out the cliexa mobile platform for Rheumatoid Arthritis, cliexa-RA: //www.cliexa.com/cliexamobile/rheumatoid-arthritis/

2. Pain Management, Primary Care, & Integrative Medicine

Chronic pain, affecting over 10% of American adults, is a leading cause of opiate abuse. Managing and overcoming chronic pain is a complex obstacle for many healthcare providers. With the increased shift away from the prescribing of opioids in the treatment of chronic pain, cliexa enables providers to remotely monitors opioid-prescribed patients while empowering them to relay their patient-reported outcomes and track their mental health conditions in association with their chronic pain, while catering specifically towards the individual needs of each patient-provider relationship.

Check out the cliexa mobile platform for Pain Management, cliexa-EASE: //www.cliexa.com/cliexamobile/pain-management/

3. Behavioral Health & Addiction Treatment

Though struggles with addiction are becoming increasingly more prevalent in society, the present methods of addiction treatment are limited. Through innovations in health technologies, patients and providers are shifting towards new ways of treating addiction. The monitoring of patients in real-time is essential for positive treatment outcomes for both patients and their providers. By leveraging patient-reported data, patients adhere to their treatment plans and overcome addiction as a disease, rather than as a fault.

Check out the cliexa mobile platform for Behavioral Health, cliexa-SENSE: //www.cliexa.com/cliexamobile/behavioral-health/

4. Digestive Health

Through cliexa innovations, providers better manage chronic gastrointestinal diseases, such as inflammatory bowel disease or ulcerative colitis, using specifically-designed, highly-structured treatment plans that leverage disease activity scoring models taken from qualitative patient responses to assessments which quantify and track symptoms over long periods of time.

Check out the cliexa mobile platform for Digestive Health, cliexa-IBD: //www.cliexa.com/cliexamobile/inflammatory-bowel-disease/

5. Respiratory Care

cliexa enables providers to qualitatively track chronic diseases of the respiratory system, like chronic obstructive pulmonary disease (COPD), through remote patient-reported outcomes. The ability to structure individualized and specialized care leads to improved patient-provider experiences.

Check out the cliexa mobile platform for Respiratory Care, cliexa-COPD: //www.cliexa.com/cliexamobile/chronic-obstructive-pulmonary-disease/

6. Pediatric Care

cliexa health technology drives innovations in mental health resiliency in adolescents, a hot topic in today’s health community. cliexa’s clinically validated medical assessment applications, coupled with its mHealth prevention services, help providers identify and reduce risk behaviors in adolescents and young adults. cliexa’s mobile patient-engagement applications equip providers with the tools adolescents use to overcome anxiety and depression, increasing the overall quality-of-care for both patients and providers.

Check out the cliexa mobile platform for Pediatric Care, cliexa-OPTIONS: //www.cliexa.com/cliexamobile/adolescent-resiliency/

STDs are a persistent enemy
STDs are a persistent enemy

…Jonathan Mermin, director of the CDC’s National Center for STDs and TB Prevention, said in a news release last month. He added that the epidemic is, “…growing in number, and outpacing our ability to respond.” Over 50% of new cases of STDs occur in young people ages 15 – 24, Chlamydia cases the most prominent. Front-line defense–primary care clinics and overloaded physicians. They may feel they do not get honest answers or they don’t have time to ask difficult questions. Young people are not comfortable with face-to-face discussions about reproductive health.

Some physicians don’t know how to broach this sensitive conversation, “This is an awkward topic, especially for men and they avoid having these conversations. cliexa-OPTIONS gives male physicians and clinicians a tool to get through the awkwardness …This epidemic impacts females more because they are left holding the bag.”   So is it a lost cause? No, digital health offers promising solutions.

Why is Primary Care so Important?

Leveraging long-standing relationships with pediatricians and family physicians–an underutilized strategy on the front lines of this devastating battle, helps youth stay healthy. Young people respond to authentic conversations with people they know and trust.  Primary care screenings identify most new cases of Chlamydia. That’s where the cliexa-OPTIONS App, an innovative digital health technology,  plays a crucial role.

cliexa-OPTIONS reduces the cognitive load for clinicians by creating a structured report using our unique scoring algorithm. Our measures are more sensitive to cultural trends young people experience. Three levels of high risk allow tailored, pinpointed conversations that count. Our recent clinical pilot confirmed the benefits of the OPTIONS App.

Risk assessment quality was average before piloting the cliexa-OPTIONS App. After implementing cliexa-OPTIONS, physicians rated the quality of their sexual risk assessment as excellent. The cliexa-OPTIONS App improves reproductive health counseling by “making it easier for my patients to discuss what is REALLY going on with them.” Physicians said the App saves them time and all participants reported that cliexa-OPTIONS supports early identification of youth at highest risk of acquiring an STD.

Positive ROI increases revenue improves quality, tracks efforts, and supports better outcomes for young people. What’s not to love about the cliexa-OPTIONS App?? To find out how to get started, contact the cliexa team.

On October 19th, cliexa will pitch to improve the healthcare industry for a chance to pilot cliexa Platform with Colorado’s leading healthcare systems, payors, and provider networks.

Early this summer, healthcare innovators from around the country submitted applications to compete in the Prime Health Challenge, the country’s largest digital health pitch competition of its kind.  Over the past 3-months, experts from across the industry have evaluated the proposals through the Prime Health Qualify process and narrowed the list down to six finalists who will compete in the live, shark-tank style event at the Exdo Event Center in RiNo Denver.  Thanks to funding from The Colorado Health Foundation, winners will be rewarded with a share of the $150,000 prize and the opportunity to prove their solutions in real-life clinical settings.

Read more at this link.

Colorado health companies compete in $150,000 pitch contest – BizWest

Prime Health Challenge to feature six digital startup finalists vying for $150K – InnovatioNews

//primehealthchallenge.com/compete/

//cybermednews.com/companies/finalists-announced-prime-health-challenge/#

Venture Hall accelerator program today announced cliexa (www.cliexa.com) to receive a zero-equity investment of $25,000, as awarded by their peers.

Also announced at Maine Startup Insider website, cliexa won the 1st place award.

Developed in partnership with Village Capital, an international accelerator and venture capital firm, Venture Hall’s program includes an intense peer-review process that has been shown to forecast success better than investors.

“We are honored and feel extremely lucky to be part of Venture Hall Accelerator Program this summer as cliexa. It was not just an accelerator program with just mentor and training sessions, but also working sessions with industry experts and clinicians directly from Maine Health and Unum,”said Mehmet Kazgan, CEO and co-founder of cliexa,” Venture Hall’s program played an amazing catalyzer role by working on specific areas for each startup and reached out to exactly the right group of resources from mentors pool. We came with a list of goals to Portland, Maine and Venture Hall made those happen. cliexa would love to be part of Maine’s economic growth.”

The six startup teams to complete the accelerator were selected from a competitive applicant pool of over 90 companies from 27 states and 12 countries. The accelerator program was delivered in partnership with MaineHealth and Unum to bring more world-class startup talent to Maine, and to provide a way for employees of both partner organizations to assist in the development of innovative new solutions to challenging problems.